Pathway to Independence Award (K99/R00 Clinical Trial Required)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026
Can you apply?
This grant is for postdoctoral researchers transitioning to independence in cancer research. Applicants must have a doctoral degree (MD, PhD, DVM, DDS, DO) or equivalent and be within 5 years of postdoctoral training start. Career development mentorship and institutional support are required.
Both U.S. and international applicants are eligible, though international applicants must have U.S. sponsorship. Foreign institutions may apply in limited circumstances. This is a two-phase award: the K99 phase provides mentored research support, and the R00 phase funds independent research following a transition period.
The grant supports original cancer research across all NCI-designated areas. Applicants must demonstrate commitment to establishing independent careers as cancer researchers. A clinical trial component is required for this variant.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NCI research support during this transition in order to help awardees to launch competitive, independent research careers.
Who can apply
Eligible applicants
- 501(c)(3) Public Charity
- City / Municipal Government
- County Government
- Nonprofits
- Postdoctoral Researcher
- Private University
- Public Authority
- Public K-12 School
- Public University
- Researcher (independent)
- Small Business (SBA-defined)
- Special District
- State Government
- Tribal Nation
- Tribal Organization
How to apply
Application links
Required documents
- SF-424 (R&R)
- Project Narrative (Research Plan and Career Development Plan)
- Biographical Sketch (applicant, mentor, co-mentors)
- Letters of Support (mentor, institutional sponsors)
- Mentor's Biographical Sketch
- Budget and Budget Justification
- Facilities and Resources
- Clinical Trial Protocol (if applicable)
- Previous Funding/Conflict of Interest Certification
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.398 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$23,853,515
-
$22,820,040
-
$17,454,036
-
$15,407,472
-
$14,832,927
-
$14,410,208
-
$14,234,718
-
$14,219,981
-
$13,766,537
-
$13,734,930
Top States by Funding
- CA 14 awards $114.6M
- MA 10 awards $104.9M
- TX 9 awards $102.7M
- NY 9 awards $65.8M
- NC 6 awards $62.1M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.398). How funding has trended year over year.
| 2024 | $228,173,992 | |
| 2025 | $213,201,522 | |
| 2026 est. | $135,455,000 |
FAQ
Who can apply for the K99/R00 award?
Postdoctoral researchers with an MD, PhD, or equivalent degree within 5 years of postdoctoral training. You must have institutional sponsor and mentor commitments.
Is this award available to international applicants?
Yes, but international applicants must have U.S. sponsorship and meet specific visa requirements. Your institution must support your candidacy.
What is the timeline for this two-phase award?
The K99 phase typically lasts 2-3 years of mentored research. After successful transition, the R00 phase provides independent research funding for up to 3 years.
How competitive is this award?
K99/R00 is highly competitive, especially for clinical trials. Strong mentor recommendations, preliminary data, and a clear career plan are essential for success.
What research activities are funded?
Original cancer research, mentored training, transitional activities, and clinical trial work. All NCI cancer-related topics are eligible if well-justified.
💡 Tips for applicants
- Build relationships with strong mentors early. Your mentor's reputation and written support significantly influence reviewer decisions.
- Include preliminary data demonstrating research independence. Show you've contributed original ideas, not just participated in mentor's work.
- Develop a clear transition plan from mentorship to independence. Explain specific milestones and timeline for establishing your own lab.
- Address clinical trial requirements explicitly. Describe your trial design, patient population, and regulatory pathway clearly.
- Obtain strong institutional commitment letters. Show your institution will provide space, resources, and support for your independent career phase.
⚠️ Common mistakes
Weak mentor selection or insufficient documentation of mentor availability damages competitiveness. Vague or overly ambitious transition plans without realistic milestones get rejected. Insufficient preliminary data makes it difficult to demonstrate research readiness and independence.
Similar grants
- OPEN NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Required) — National Institutes of Health
- OPEN NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Not Allowed) — National Institutes of Health
- OPEN NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) — National Institutes of Health
- OPEN NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) — National Institutes of Health